The patient with hypertension

Quintessence International

Volumn 32, Issue 9, 2001, Pages 671-690

  Riley, Catherine K ^a   Terezhalmy, Geza T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ANAMNESIS; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; DENTAL ANESTHESIA; DENTAL CARE; EMERGENCY TREATMENT; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; HYPOTENSION; LICHEN PLANUS; PERIODONTAL DISEASE; REVIEW; RISK; UNITED STATES; XEROSTOMIA;

ANESTHESIA, DENTAL; CALCIUM CHANNEL BLOCKERS; CORONARY DISEASE; DENTAL CARE FOR CHRONICALLY ILL; EMERGENCY TREATMENT; GINGIVAL HYPERPLASIA; HUMANS; HYPERTENSION; HYPOTENSION; LICHEN PLANUS, ORAL; MEDICAL HISTORY TAKING; NIFEDIPINE; PERIODONTAL DISEASES; RISK; UNITED STATES; XEROSTOMIA;

EID: 0035490171     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (156)

1. Corvol P, Jeunemaitre X, Charru N, Kotelevtsev Y, Soubrier F. Role of renin-angiotensinogen system in blood pressure regulation and in human hypertension: New insights from molecular genetics. Rec Prog Horm Res 1995;50:287-308.
2. McNight JA, Moore TJ. The effect of dietary factors on blood pressure. Compr Ther 1994;20:511-517.
3. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III. Analysis of data from trials within populations. BMJ 1991;302:819-824.
4. Pan WH, Nanas S, Dyer A, et al. The role of weight in the positive association between age and blood pressure. Am J Epidemiol 1991;124:621-623.
5. Beilin LJ. Non-pharmacological management of hypertension: Optimal strategies for reducing cardiovascular risk. J Hypertension 1994;12(suppl 10):S71-S81.
6. Hilton PJ. Cellular sodium transport in essential hypertension. N Engl J Med 1986;314:222-229.
7. Bell PD, Mashburn N, Unlap MT. Renal sodium/calcium exchange: A vasodilator that is defective in salt-sensitive hypertension. Acta Physiol Scand 2000;168:209-214.
8. Grienling KK, Alexander RW. Cellular mechanisms in angiotensin II action. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994;11: 244-252.
9. Lindop GB. The effects of hypertension on the structure of human resistance vessels. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994: 663-669.
10. Granger VP, Alexander BT. Abnormal pressure natriuresis in hypertension: Role of nitric oxide. Acta Physiol Scand 2000;168:161-168.
11. Takeda R, Myamori I. Endocrine and auto-paracrine factors in the pathogenesis of primary hypertension. Hypertens Res 1995;18:171-179.
12. Compese VM, Nosrati S. Diagnosis and evaluation of secondary hypertension. Clin Cornerstone 1999;2:27-39.
13. Carvalho JJ, Baruzzi RG, Howard PF, et al. Blood pressure in four remote populations in the Intersalt Study. Hypertension 1989;14:238-247.
14. Poulter NR, Sever PS. Blood pressure in other populations. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific Publications, 1994:22.
15. Cost E, Rose G, Klein C, et al. Salt and blood pressure in Rio Grance do Sul, Brazil. Bull Pan Am Health Organ 1995;24:159-176.
16. Joffres MR, Hamet P, Rabkin SW, Gelsky D, Hogan K, Fodor G. Canadian Heart Health Surveys Research Group. Prevalence, control and awareness of high blood pressure among Canadian adults. Can Med Assoc J 1992;146: 1997-2005.
17. Silagy CA, McNeil JH. Epidemiologic aspects of isolated systolic hypertension and implications for future research. Am J Cardiol 1992;69:213-218.
18. Tuomilehto J, Zimmet P, Taylor R, Bennett P, Kanakaanpaa J, Wolf E. A cross-sectional analysis of blood pressure and its determinants in eleven Pacific populations. J Am Coll Nutr 1989;8:151-165.
19. Whelton PK. Blood pressure in adults and the elderly. In: Bulpitt CJ (ed). Handbook of Hypertension. Amsterdam: Elsevier, 1985:51-69.
20. Wu YK, Lu CQ, Gao RC, Yu JS, Lui GC. Nation-wide hypertension screening in China during 1979-1980. Chin Med J (Engl) 1982;95(2):101-108.
21. Ram VC. Secondary hypertension: Workshop and correction. Hosp Pract 1994;29:137f.
22. De Leeuw PW, Gaillard CA, Brikenhager WH. The kidney in hypertension. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994:698-711.
23. Ljungman S, Aurell M, Hartford M, Wikstrand J, Wilhelmsen L, Berglund G. Blood pressure and renal function. Acta Med Scand 1980;208:17-25.
24. Heagerty AM, Aalkjaer C, Korsgaard J, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: Dual process of remodeling and growth. Hypertension 1993;21:391-397.
25. Kannel WB, Sorlie P. Left ventricular hypertrophy in hypertension: Prognostic and pathogenic implications-The Farmington Study. In: Stauer BE (ed). The Heart in Hypertension. Berlin: Springer, 1981:223-242.
26. Schetter G. Angina pectoris und arteriosklerose. In: Gill E (ed). Angina Pectoris. Stuttgart: Fischer, 1978:227-235.
27. Siegenthaler W, Veragut M, Werning C, Wheton PK, Jiang HE, Klay MJ. Blood pressure in westernized popupations. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994:11-12.
28. Stauer BE, Motz W, Schwartzkopff B, Vester E, Lesschke M, Scheler S. The heart in hypertension. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994:712-731.
29. MacMahon S, Rodgers A. Blood pressure, antihypertensive treatment and stroke. J Hypertens 1994;12(suppl 10): S5-S14.
30. MacMahon S. Blood pressure and the risk of cardiovascular disease. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994:46-57.
31. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 153:154-183.
32. Gifford RW Jr, Kirkendall W, O'Conner ET, Weidman W. Office evaluation of hypertension. A statement for health professionals by a writing group of the Council for High Blood Pressure Research, American Heart Association. Circulation 1998;79:721-731.
33. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension; their course and prognosis. Am J Med Sci 1939;197:332-343.
34. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risk. US population data. Arch Intern Med 1993;153:598-615.
35. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 1992;152:56-64.
36. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988;77:504-514.
37. Madhaven S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23: 395-401.
38. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
39. Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of mild hypertension study. Final results. J Am Med Assoc 1993;270:713-724.
40. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27: 1214-1218.
41. Insua JT, Sachs HS, Lau TS, et al. Drug treatment of hypertension in the elderly: A meta-analysis. Ann Intern Med 1994;121:355-362.
42. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of random trials. J Am Med Assoc 1994; 272:1932-1938.
43. Collins R, Peto R, Gadwin J, MacMahon S. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335: 827-838.
44. Herbert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-581.
45. Gifford RW Jr, Kaplan NM. Thiazides and hypertension in the elderly [commentary]. Hypertension 1995;25:1052.
46. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
47. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after mycardial infarction. Results of the Survival and Ventricular Enlargement Trial (SAVE). N Engl J Med 1992;327:669-677.
48. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. The Collaborative Group on ACE Inhibitors Trials. J Am Med Assoc 1995; 273:1450-1456.
49. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-1462.
50. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: An overview of the randomized trial. Prog Cardiovasc Disc 1985;27: 335-371.
51. Kaplan NM, Gifford RW Jr. Choice of initial therapy for hypertension. J Am Med Assoc 1996;275:1577-1580.
52. Cody RJ. The clinical potential of renin inhibitors and angiotensin antagonists. Drugs 1994;47:586-598.
53. Ross R. Atheroslcerosis: An inflammatory disease. N Engl J Med 1999;340:115-126.
54. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: A risk factor for coronary heart disease. Ann Periodontol 1998;3:127-141.
55. Syrjanen J, Peltola J, Valtonen V, Iivannnainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med 1989;25:179-184.
56. Mattila KJ, Nieminen MS, Valtonen V, et al. Association between dental health and acute myocardial infarction. Br Med J 1989;298:779-781.
57. Genco RJ. Periodontal disease and risk for myocardial infarction and cardiovascular disease. Cardiovasc Rev Rep 1998;19:34-40.
58. Dorn BR, Dunn WA, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999;67:5792-5798.
59. Beck JD, Pankow J, Tyroler HA, Offenbacker S. Dental infections and atherosclerosis. Am Heart J 1999;138: S528-S533.
60. Valtonen VV. Role of infection in atherosclerosis. Am Heart J 1999;138:S431-S433.
61. Position Paper, the American Academy of Periodontology. Periodontal disease as a potential risk for systemic disease. J Periodontol 1998;69:841-850.
62. Nery EB, Meister F, Ellinger RF, Eslami A, McNamara TJ. Prevalence of medical problems in periodontal patients obtained from three different populations. J Clin Periodontol 1987;58:564-568.
63. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993;306:688-691.
64. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi DL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993;103:205-211.
65. Umino M, Nagao M. Systemic diseases in elderly dental patients. Int Dent J 1993;43:213-218.
66. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infection and the risk of new coronary events: Prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20:588-592.
67. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willet WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-1636.
68. Beck JD, Garcia RI, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-1137.
69. Grau AJ, Buggle F, Ziegler C, et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 1997;28:1724-1729.
70. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. J Am Med Assoc 2000;284:1406-1410.
71. Hay KD, Reade PC. Methyldopa as a cause of oral mucous membrane reactions. Br Dent J 1978;145:195-203.
72. Williams BG. Oral drug reaction to methyldopa. Oral Surg Oral Med Oral Pathol 1983;56:375-377.
73. Brooks SL. Lichenoid reaction of oral mucosa and skin to methyldopa. J Oral Med 1982;37:42-44.
74. Firth NA, Reade PC. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. 1989;67:41-44.
75. Robertson WR, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992;74:183-185.
76. Hay KD, Reade PC. Spectrum of oral disease induced by drugs and other bioactive agents. Drugs 1982;26:268-277.
77. Eversole LE. Allergic stomatitides. J Oral Med 1979;34: 93-102.
78. Reed WD, Becker SW. Lichenoid drug eruptions from gold, chroroquine, and chlorothiazide. GP 1962;25: 118-123.
79. Van Dis ML, Parks ET. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol 1995;79:696-700.
80. Zelickson BD, Rogers RS. Oral drug reactions. Dermatol Clin 1987;5:695-708.
81. Glass BJ, Van dis ML, Langlais RP, Miles DA. Xerostomia: Diagnosis and treatment planning considerations. Oral Surg Oral Med Oral Pathol 1984;5:248-252.
82. Schubert MM, Izutsu KT. Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987;66:680-688.
83. Felder RS, Millar SB, Henry RH. Oral manifestations of drug therapy. Spec Care Dent 1988;May-June:119-124.
84. Sreebny LM, Valdini A, Yu A. Xerostomia. II. Relationship to nonoral symptoms, drugs, and disease. Oral Surg Oral Med Oral Pathol 1989;68:419-427.
85. Persson RE, Izusu KT, Truelove EL, Rersson R. Differences in salivary rates in elderly subjects using xerostomic medications. Oral Surg Oral Med Oral Pathol 1991;72:42-46.
86. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991; 2:103-137.
87. Rees TD, Levine RA. Systemic drugs as a risk factor for periodontal disease initiation and propogation. Compend Contin Educ Dent 1995;16:20-42.
88. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:205-313.
89. National Center for Health Statistics. Health, United States, 1996. Hyattsville, MD: US Public Health Service, 1997.
90. National High Blood Pressure Education Program Working Group. 1995 Update of the Working Group Reports on Chronic Renal Failure and Renovascular Hypertension. Arch Intern Med 1996;156:1938-1947.
91. US Renal Data System. USRDS 1997 Annual report. Bethesda, MD: US Dept of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Disease, 1997.
92. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival. Secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-380.
93. National Heart, Lung, and Blood Institute. Fact Book Fiscal Year 1996. Bethesda, MD: US Dept of Health and Human Services, National Institutes of Health, 1997.
94. Graves EJ. Detailed diagnoses and procedure, National Hospital Discharge Survey, 1989, Dept of Health and Human Services, publication 91-1769. Hyattsville, MD: National Center for Health Statistics, 1991.
95. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression of hypertension to congestive heart failure. J Am Med Assoc 1996;175:1557-1562.
96. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-1963.
97. Allen LH, Ming KI-I, Neal RG. Blood pressure and electrocardiographic response to dental treatment with use of local anesthesia. J Am Dent Assoc 1986;113:639-642.
98. Boakes AJ, Laurence DR, Lovel KW, O'Neil R, Verrill PJ. Adverse reactions to local anaesthetic/vasoconstrictor preparations. Br Dent J 1972;133:137-140.
99. Meiller TF, Overholser CD, Kutcher MJ, Bennett R. Blood pressure fluctuations in hypertensive patients during oral surgery. J Oral Maxillofac Surg 1983;41:715-718.
100. Lipp M, Dick W, Daublander M, Fuder H, Stanton-Hicks M. Exogenous and endogenous plasma levels of epinephrine during dental treatment under local anesthesia. Reg Anesth 1993;18:6-12.
101. Massalha R, Valdman S, Farkash P, Merkin L, Herishanu Y. Fatal intracerebral hemorrhage during dental treatment. Isr J Med Sci 1996;32:774-776.
102. Mito RS, Yagiela JA. Hypertensive response to levonordefrin in a patient receiving propranolol: Report of case. J Am Dent Assoc 1988;116:55-57.
103. Meyer FU. Hemodynamic changes of local anesthesia in normotensive and hypertensive subjects. Int J Clin Pharmacol Ther Toxicol 1986;24:477-481.
104. Steinman HR, Patterson SS, Newton CW, Troup P, Zipes DP. Cardiovascular changes during nonsurgical endodontics. J Endod 1982;8:497-501.
105. Singer J, Meiller TF, Rubinstein L. Blood pressure fluctuations during dental hygiene treatment. Dent Hyg 1983; 57(8):24-28.
106. Beck FM, Weaver JM. Blood pressure and heart rate responses to anticipated high stress dental treatment. J Dent Res 1981;60:26-29.
107. Meiller TF, Overholser CD, Kutcher MJ, Bennet R. Blood pressure fluctuations in hypertensive patients during oral surgery. J Oral Maxillofac Surg 1983;41:715-718.
108. Cioffi GA, Chernow B, Glahn RP, Terezhalmy GT, Lake CR. The hemodynamic and plasma catecholamine responses to routine restorative dental care. J Am Dent Assoc 1985;111:67-70.
109. Ship II. The response of systolic and diastolic blood pressures to dental stress. Oral Surg Oral Med Oral Pathol 1960;13:499-507.
110. Gortzak RAT, Oosting J, Abraham-Inpijn L. Blood pressure response to routine restorative dental treatment with and without local anesthesia. Oral Surg Oral Med Oral Pathol 1992;73:677-681.
111. Niwa H, Satoh Y, Matsuura H. Cardiovascular responses to epinephrine-containing local anesthetics for dental use: A comparison of hemodynamic responses to infiltration anesthesia and ergometer-stress testing. Oral Surg Oral Med Oral Pathol 2000;90:171-181.
112. Bruce RA. Exercise testing for evaluation of ventricular function. N Engl J Med 1977;296:671-675.
113. Kenney WL (ed). ACSM's Guidelines for Exercise Testing and Prescription, ed 5. Baltimore: Williams & Wilkins, 1995:93-94.
114. Fox SM III, Naughton JP, Gorman PA. Physical activity and cardiovascular health. II. The exercise prescription: Intensity and duration. Mod Concepts Cardiovasc Dis 1972;41:21-24.
115. Froelicher VF, Quaglietti S. Handbook of Exercise Testing. Boston: Little, Brown, 1996:62.
116. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index). Am J Cardiol 1989;64:651-654.
117. Mandel ID. The plaque fighters. J Am Dent Assoc 1993; 124:71-73.
118. Youngblood JJ, Killoy W, Love JW, Drisko C. Effectiveness of a new home plaque removal instrument in removing subgingival and interproximal plaque: A preliminary in vivo report. Compend Contin Educ Dent 1985;6: S128-S132.
119. Baab DA, Johnson RH. The effect of new electric toothbrush on supragingival plaque and gingivitis. J Periodontol 1989;60:336-341.
120. Killoy WJ, Love JW, Love J, Fedi PF Jr, Tira DE. The effectiveness of a counterrotary action powered toothbrush and conventional toothbrush on plaque removal and gingival bleeding. A short-term study. J Periodontol 1989;60: 473-477.
121. Wilcoxon DB, Ackerman RJ Jr, Killoy WS, Love JW, Sakumura JS, Tira DE. The effectiveness of a counter-rotational action power toothbrush on plaque control in orthodontic patients. Am J Orthod Dentofac Orthop 1991; 99:7-14.
122. Wilson S, Levine D, Dequincy G, Killoy W. Effects of two toothbrushes on plaque, gingivitis, gingival abrasion and recession: A one-year longitudinal study. Compend Contin Educ Dent 1993;Suppl 16:S569-S579.
123. Wilson S, Levine D, Dequincy G, Killoy WJ. Effects of two toothbrushes on plaque, gingivitis, gingival abrasion and recession: A one-year longitudinal study. Compend Contin Educ Dent 1993;14(suppl 16):S69-S79.
124. Yukna RA, Shaklee RL. Interproximal vs midradicular effects of a counterrotational powered brush during supportive periodontal therapy. Compend Contin Educ Dent 1993;14(suppl 16):S80-S86.
125. Love JW, Drisko CL, Killoy WJ, Tira DE, Love JD. Clinical assessment of the Interplak powered toothbrush vs a conventional brush plus floss. Compend Contin Educ Dent 1993;14(suppl 16):S87-S98.
126. Blahunt P. A clinical trial of the Interplak powered toothbrush in a geriatric population. Compend Contin Educ Dent 1993;14(suppl 16):S606-S610.
127. Terezhalmy GT, Gagliardi VB, Rybicki LA, Kauffman MJ. Clinical evaluation of the efficacy and safety of the Ultra-Soex ultrasonic toothbrush: A 30-day study. Compend Contin Educ Dent 1994;15:866-874.
128. Terezhalmy GT, Iffland H, Jelepis C, Waskowski J. Clinical evaluation of the effect of an ultrasonic toothbrush on plaque, gingivitis, and gingival bleeding: A six-month study. J Prosthet Dent 1995;73:97-103.
129. Whitmyer CC, Terezhalmy GT, Miller DL, Hujer ME. Clinical evaluation of the efficacy and safety of an ultrasonic toothbrush system in an elderly patient population. 1998;19:29-33.
130. Shinada K, Hashizume LN, Teraoka K, Kurosaki N. Effect of ultrasonic toothbrush on Streptococcus mutans. Jpn J Conserv Dent 1999;42:410-417.
131. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-417.
132. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Sixth Report. Arch Intern Med 1997;157:2413-2446.
133. Funakoshi Y, Ichiki T, Ito K, Takeshita A. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 1999;34:118-125.
134. Muller DN, Dechend R, Mervaala EM, et al. NF-kB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000;35:193-201.
135. Furchgott RF, Zawadzky JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
136. Kuchan MJ, Jo H, Frangos JA. Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells. Am J Physiol 1994;267:C753-C758.
137. Okada M, Matsumori A, Ono K, et al. Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:894-901.
138. Wung BS, Cheng JJ, Chao YJ, Lin J, Shyy YJ, Wang DL. Cyclic strain increases monocyte chemotactic protein-1 secretion in human endothelial cells. Am J Physiol 1996; 270:H1462-H1468.
139. Touyz RM, Milne FJ. Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension. J Hypertens 1995;13:867-874.
140. MacArthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 1994; 200:395-400.
141. Verhaar MC, Beutler JJ, Gaillard CA, Koomans HA, Fijnheer R, Rabelink TJ. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens 1998;16:45-50.
142. Eckberg D-L. Parasympathetic cardiovascular control in human disease: A critical review of methods and results. Am J Physiol 1980;239:H581-H593.
143. Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med 1986;80:429-434.
144. Lipsitz LA, Pluchino FC, Wei JY, Rowe JW. Syncope in institutionalized elderly: The impact of multiple pathological conditions and situational stress. J Chronic Dis 1986; 39:619-630.
145. Davis BR, Langford HG, Blaufox MD, Curb JD, Polk BF, Shulman NB. The association of postural changes in systolic blood pressure and mortality in persons with hypertension: The Hypertension Detection and Follow-up Program experience. Circulation 1987;75:340-346.
146. Lipsitz LA, Pluchino FC, Wei JY, Minaker KL, Rowe JW. Cardiovascular and norepinephrine responses following meal consumption in elderly (older than 75 years) persons with post-prandial hypotension and syncope. Am J Cardiol 1986;58:810-815.
147. Kennedy GT, Crawford MH. Optimal position and timing of blood pressure and heart rate measurements to detect orthostatic changes in patients with ischemic heart disease. J Cardiac Rehabil 1984;4:219-223.
148. Dole WP, O'Rourke RA. Pathophysiology and management of cardiogenic shock. Curr Probl Cardiol 1938;8: 1-72.
149. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994;330:1724-1730.
150. Harnarayan C, Bennett MA, Pentecost BL, Brewer DB. Quantitative study of infracted myocardium in cardiogenic shock. Br Heart J 1970;32:728-732.
151. Page DL, Caulfield JB, Kastor JA, DeSanctis RW, Sanders CA. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971;285:133-137.
152. Alonso DR, Scheidt S, Post M, Killip T. Pathophysiology of cardiogenic shock: Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation 1973;48:588-596.
153. Scheidt S, Ascheim R, Killip T III. Shock after acute myocardial infarction: A clinical and hemodynamic profile. Am J Cardiol 1970;26:556-564.
154. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: Incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol 1989;14:40-46.
155. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S, SPRINT Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome. Am J Med 1993;94:265-273.
156. Wackers FJ, Lie KI, Becker AE, Durrer D, Wellens HJ. Coronary artery disease in patients dying from cardiogenic shock or congestive heart failure in the setting of acute myocardial infarction. Br Heart J 1976;38:906-910.